Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential

被引:215
作者
Tondreau, T [1 ]
Lagneaux, L [1 ]
Dejeneffe, M [1 ]
Delforge, A [1 ]
Massy, M [1 ]
Mortier, C [1 ]
Bron, D [1 ]
机构
[1] Inst Jules Bordet, Lab Hematol Expt, B-1000 Brussels, Belgium
关键词
BM; differentiation; expansion; mesenchymal stem cells;
D O I
10.1080/14653240410004943
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background BM mesenchymal stem cells ( MSC) have the capacity for renewal and the potential to differentiate into multiple tissues. In this study, we compared different enrichment methods to obtain MSC from BM. Methods Three different methods were compared with a view to obtaining MSC more rapidly from BM: negative selection (RosetteSep and MACS) and plastic adhesion. The three cell fractions were grown in complete alpha-minimum essential medium in order to evaluate their proliferative capacity, their phenotype during culture and their potential to differentiate into adipocytes, osteocytes and chondrocytes. Identification of MSC was performed by immunofluorescence with putative mesenchymal markers SH2 and SH3 but also with hematopoietic markers. Results After negative selection, only 1 +/- 0.2% and 2.9 +/- 0.8% of cells were recovered from BM with the RosetteSep and MACS methods, respectively. However, negative depletion permitted a homogeneous population of MSC, with more than 90% SH2(+) and SH3(+) cells, to be obtained rapidly and in large quantities after 10 days of culture. Similar homogeneity was observed after three passages if the plastic adhesion was used as selection method and after an average of 25 - 30 days of culture. Different levels of MSC maturity were also suggested by the variable level expression of Stro-1. Discussion Depleting selection by RosetteSep may represent an easy method of obtaining MSC rapidly from BM with the aim of potential therapeutic use.
引用
收藏
页码:372 / 379
页数:8
相关论文
共 30 条
[1]
Characteristics of adherent, fibroblast-like hematopoietic stem cells [J].
Bertolini, L .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (05) :607-609
[2]
Byers RJ, 1999, J PATHOL, V187, P374, DOI 10.1002/(SICI)1096-9896(199902)187:3<374::AID-PATH257>3.0.CO
[3]
2-V
[4]
Mesenchymal stem cells: building blocks for molecular medicine in the 21st century [J].
Caplan, AI ;
Bruder, SP .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) :259-264
[5]
Mesenchymal stem cells: Biology and potential clinical uses [J].
Deans, RJ ;
Moseley, AB .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) :875-884
[6]
In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP [J].
Deng, WW ;
Obrocka, M ;
Fischer, I ;
Prockop, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (01) :148-152
[7]
The STRO-1+marrow cell population is multipotential [J].
Dennis, JE ;
Carbillet, JP ;
Caplan, AI ;
Charbord, P .
CELLS TISSUES ORGANS, 2002, 170 (2-3) :73-82
[8]
Role of mesenchymal stem cells in hematopoietic stem cell transplantation [J].
Devine, SM ;
Hoffman, R .
CURRENT OPINION IN HEMATOLOGY, 2000, 7 (06) :358-363
[9]
Encina NR, 1999, LAB INVEST, V79, P449
[10]
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [J].
Horwitz, EM ;
Prockop, DJ ;
Fitzpatrick, LA ;
Koo, WWK ;
Gordon, PL ;
Neel, M ;
Sussman, M ;
Orchard, P ;
Marx, JC ;
Pyeritz, RE ;
Brenner, MK .
NATURE MEDICINE, 1999, 5 (03) :309-313